Addressing the totality of evidence for ivermectin
When assessing repurposed drugs in a pandemic situation, the totality of evidence should be considered rather than RCTs alone; had this been done the pandemic could have been […]
When assessing repurposed drugs in a pandemic situation, the totality of evidence should be considered rather than RCTs alone; had this been done the pandemic could have been […]
Boiling peanuts for up to 12 hours could help overcome children’s allergic reactions, according to the results of a clinical trial which found up to 80% of children […]
The TOGETHER trial was widely reported as showing that ivermectin was not effective in covid-19, but a straightforward analysis of the results reveals a 59 per cent reduction […]
The European Medicines Agency (EMA) has approved four new medicines at its January meeting, getting 2023 off to a low-key start. The Agency’s key human medicines committee (CHMP) […]
The best time to administer ivermectin is at the beginning of a covid-19 infection so that virus is killed and disease progression averted, according to Colleen Aldous, Professor […]
Professor Ashok Soni OBE is a community pharmacist and president of the National Association of Primary Care. He is also a non-executive director at Oxford University Hospitals and […]
A research team, led by Professor Sung Ho Park in the Department of Biological Sciences at UNIST announced the results of a study on osteoblasts that damage joint bones […]
As President of the National Association for Primary Care, Professor Ashok Soni OBE, hopes to use his position be a voice on behalf of the broader perception of […]
Professor Colleen Aldous is a research professor at the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial of […]
Caregivers need care, too. And now, researchers from Japan have found that their experience with healthcare professionals while caring for someone else affects their own healthcare choices. In […]
Reducing harm from medicines and improving the patient experience are two objectives that go hand in hand and building in pharmaceutical expertise from the outset is a powerful […]
Migraine is a major cause of disability, affecting about 12% of people. A 2-part series published in CMAJ (Canadian Medical Association Journal) on diagnosing and managing the condition with both […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.